J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
1,846.00
-10.30 (-0.55%)
At close: Jan 29, 2026
NSE:JBCHEPHARM Market Cap
NSE:JBCHEPHARM has a market cap or net worth of 295.96 billion as of January 29, 2026. Its market cap has increased by 2.03% in one year.
Market Cap
295.96B
Enterprise Value
290.43B
Revenue
41.93B
Ranking
n/a
PE Ratio
39.26
Stock Price
1,846.00
Market Cap Chart
Since December 11, 2001, NSE:JBCHEPHARM's market cap has increased from 408.70M to 295.96B, an increase of 72,315.36%. That is a compound annual growth rate of 31.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 295.96B | 3.78% |
| Dec 31, 2025 | 285.18B | -0.62% |
| Dec 31, 2024 | 286.94B | 13.93% |
| Dec 29, 2023 | 251.85B | 67.53% |
| Dec 30, 2022 | 150.33B | 9.43% |
| Dec 31, 2021 | 137.38B | 74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 564.32B |
| Laurus Labs | 539.96B |
| Ipca Laboratories | 369.11B |
| Ajanta Pharma | 336.98B |
| Emcure Pharmaceuticals | 281.44B |
| Gland Pharma | 276.12B |
| Wockhardt | 219.14B |
| Piramal Pharma | 202.43B |